# SOTK earnings call intelligence LOPJLB CallCard / temporal rollup · freemium · [stock page](https://www.lopjlb.com/stock/SOTK) · [Earnings tab](https://www.lopjlb.com/stock/SOTK?tab=earnings) Updated: 2026-10-16T13:10:18 Quarters analyzed: 8 ## Cross-quarter narrative Across 8 calls for SOTK, management tone moved from +0.50 (2023 Q4) to +0.60 (2027 Q2). Latest guidance stance: maintained. Latest desk line: Sono‑Tek posted modest revenue growth and strong medical market momentum in FY27 Q2, highlighted a growing backlog and integration focus, while maintaining flat‑to‑modest guidance amid variability in large‑order timing. ## Latest CallCard · Q2 Sono‑Tek posted modest revenue growth and strong medical market momentum in FY27 Q2, highlighted a growing backlog and integration focus, while maintaining flat‑to‑modest guidance amid variability in large‑order timing. **Guidance:** maintained — Management reiterated expectation for flat to modest revenue growth for the remainder of fiscal 27. **Tone:** mgmt 0.6 · Q&A pressure 0.4 · divergence 0.2 Prepared remarks emphasized solid progress, revenue growth, margin expansion and a strong balance sheet. ### Demand visibility Increased visibility into FY28 from record backlog and new orders Backlog rose to $9.5M (up 23%) and three new clean‑energy orders of $7.19M were added, most slated to ship in FY28. ### Margins / costs Gross margin expanded to 55% driven by product mix Margin growth reflected higher contribution from medical systems and other high‑value equipment, though future margins may vary with mix. ### Capital allocation Investing in forward‑deployed engineering and selective acquisitions while maintaining a strong balance sheet Cash $17.7M, no debt; FDE team grew from 1 to 4 engineers; acquisition activity ongoing in core markets. ### Milestones - **Medical diagnostic production line order** [new]: > $3.6M order announced in August, part of FY28 backlog - **Alternative energy 10‑system order** [on_track]: $7.2M order, expected to ship primarily in fiscal 28 - **Forward‑deployed engineering team expansion** [on_track]: Team grew to 4 engineers; plan to double capacity over next 1‑2 years - **Backlog increase** [on_track]: Backlog $9.5M at Aug 31, up 23% plus $7.19M new orders - **Industrial optics shipment to defense sector** [new]: Industrial business grew ~156% driven by optics shipment to defense ### Fears / risks - **Customer concentration**: Heavy reliance on a few large integrated customers could affect revenue if they scale back. - **Talent acquisition**: Finding skilled forward‑deployed engineers is difficult and could limit growth. - **Order timing variability**: Quarter‑to‑quarter revenue can swing with the timing of high‑ASP system shipments. - **Alternative energy policy risk**: Demand in clean‑energy segment fell due to changes in government policy and spending. - **Medical market dependence**: Medical sales drove most growth; slowdown would impact overall performance. - **Integration execution risk**: Scaling integration capabilities may face execution challenges as order volume rises. ### Key quotes > “The medical market continues to be an important growth driver for the company.” > “We are reiterating our expectation for flat to modest revenue growth for this current fiscal 27.” ## Quarter one-liners - **2027 Q2:** Sono‑Tek posted modest revenue growth and strong medical market momentum in FY27 Q2, highlighted a growing backlog and integration focus, while maintaining flat‑to‑modest guidance amid variability in large‑order timing. - **2026 Q4:** Sono‑Tek posted $20.9 M revenue FY2026 with 51% gross margin, strong medical growth and a $9.1 M backlog, while clean‑energy demand fell and visibility beyond H1 FY2027 remains limited. - **2026 Q2:** Sono‑Tek reports record $10.3M first‑half revenue, solid $11.2M backlog and modest guidance uplift, while noting clean‑energy order slowdown, tariff exposure and strong medical‑device momentum. - **2025 Q4:** Sono‑Tek posted 4% FY2025 revenue growth, a solid $8.6 M backlog and higher‑ASP systems, but flagged limited full‑year visibility and clean‑energy demand uncertainty. - **2025 Q2:** Sono‑Tek reports modest Q2 revenue growth, record backlog driven by clean‑energy large‑ASP systems, and a strong outlook despite mixed regional demand and ongoing capacity upgrades. - **2024 Q4:** Sono‑Tek posted record FY2024 revenue up 31% to $19.7 M, strong backlog and guides FY2025 revenue growth of 8‑10% despite longer product cycles and rising competition. - **2024 Q2:** Sono‑Tek posted a record Q2 with 50% sales growth, strong clean‑energy demand and a $10.7M backlog, while flagging supply‑chain recovery and capacity expansion plans. - **2023 Q4:** Sono‑Tek Q4 FY2023 revenue fell 12% to $15.1 M as supply‑chain delays hit shipments, but a record backlog and growing multi‑million clean‑energy orders give management optimism for FY2024. ## Theme arcs - **Management tone** (stable): Δ mgmt=+0.10 ## Fear persistence - **supply chain** [resolved]: 2023 Q4 - **lead time** [resolved]: 2023 Q4 - **backlog conversion** [resolved]: 2023 Q4 - **funding dependence** [resolved]: 2023 Q4 - **currency impact** [resolved]: 2023 Q4 - **competitive technology** [resolved]: 2023 Q4 - **in‑house production scaling** [resolved]: 2023 Q4 - **market adoption of roll‑to‑roll** [resolved]: 2023 Q4 - **economic slowdown** [resolved]: 2024 Q2 - **margin pressure** [resolved]: 2024 Q2 ## Guidance path 2023 Q4:vague → 2024 Q2:raised → 2024 Q4:maintained → 2025 Q2:maintained → 2025 Q4:vague → 2026 Q2:raised → 2026 Q4:maintained → 2027 Q2:maintained --- Research context only. Not personalized investment advice. API: `GET /bff/api/bigfive/earnings-intel/SOTK`